Iain Dukes
Förmögenhet: 848 909 $ per 2026-09-30
Förmögenhet: 848 909 $ per 2026-09-30
Dr. Iain D.
Dukes is a Chief Executive Officer, Secretary & Director at Traws Pharma, Inc., a President at Dinas Therapeutics, Inc., a Chief Executive Officer & Director at Eilean Therapeutics LLC, a Chairman & Chief Executive Officer at Lomond Therapeutics Holdings, Inc., a Chief Executive Officer & Director at Trawsfynydd Therapeutics, Inc., a Chief Executive Officer at Viriom, Inc., a President & Director at Kartos Therapeutics, Inc., a Venture Partner at OrbiMed Advisors Private Equity, a Chairman at Iovance Biotherapeutics, Inc., a Chief Executive Officer at Lomond Therapeutics, Inc., a Chief Executive Officer & Director at Clywedog Therapeutics, Inc., a President at Telios Pharmaceuticals, Inc. and a President & Chief Executive Officer at Arrys Therapeutics, Inc. He is on the Board of Directors at Traws Pharma, Inc., Eilean Therapeutics LLC, Trawsfynydd Therapeutics, Inc., Angiex, Inc., ENYO Pharma SA, Kartos Therapeutics, Inc., Clywedog Therapeutics, Inc., Feldan Bio, Inc., Gwynant Therapeutics, Inc., NeRRe Therapeutics Holdings Ltd., NeRRe Therapeutics Ltd. and Rathlin Therapeutics Ltd. Dr. Dukes was previously employed as a Member-Supervisory Board by Themis Bioscience GmbH, a Chairman by Theseus Pharmaceuticals, Inc., an Independent Director by Ikena Oncology, Inc., a SVP & Head-Business Development by Merck Research Laboratories Massachusetts LLC, a VP-External Research & Development by Amgen, Inc., a president by BITOECH Consulting SAS, a President, Chief Executive Officer & Director by Essentialis, Inc., a VP-Scientific & Technology Licensing by GlaxoSmithKline, Inc., a Head-Exploratory Development by Glaxo Wellcome, Inc., a Principal by Glaxo, Inc., a Senior VP-Business Development & Licensing by Merck & Co., Inc., and a Non-Executive Director by ReViral Ltd. He also served on the board at KaNDy Therapeutics Ltd.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-16 | 54 000 ( 0,01 % ) | 800 280 $ | 2026-09-30 | |
TRAWS PHARMA, INC. 0,53 % | 2026-09-30 | 81 867 ( 0,53 % ) | 48 629 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Ordförande | 2016-08-16 |
| TRAWS PHARMA, INC. | Verkställande Direktör | 2025-03-31 |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Direktör/Styrelseledamot | 2017-09-08 |
Viriom, Inc.
Viriom, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antiviral and cancer medicines | Verkställande Direktör | 2019-02-01 |
Angiex, Inc.
Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Develops vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis | Direktör/Styrelseledamot | 2020-02-01 |
Arrys Therapeutics, Inc.
Arrys Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides treatments to cancer patients | Verkställande Direktör | - |
Gwynant Therapeutics
Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Develops novel small molecules for oncology targets | Direktör/Styrelseledamot | - |
Eilean Therapeutics LLC
Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in discovery and development of small molecule inhibitors therapies for hematological cancers | Grundare | 2022-01-01 |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Direktör/Styrelseledamot | - |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| Företag | Position | Slut |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 33 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Telios Pharmaceuticals, Inc.
Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
University of Bath
University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Essentialis, Inc.
Essentialis, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops breakthrough treatments for rare metabolic and endocrine diseases | Health Technology |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Glaxo, Inc. | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops vaccines to prevent infectious diseases | Health Technology |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
BITOECH Consulting SAS
BITOECH Consulting SAS Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services Provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity | Distribution Services |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Ikena Oncology, Inc.
Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Angiex, Inc.
Angiex, Inc. Miscellaneous Commercial ServicesCommercial Services Develops vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis | Commercial Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology Develops medicines for female sex hormone disorders | Health Technology |
Arrys Therapeutics, Inc.
Arrys Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides treatments to cancer patients | Health Services |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics for patients with cancer | Health Technology |
Viriom, Inc.
Viriom, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antiviral and cancer medicines | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology | Commercial Services |
Lomond Therapeutics, Inc.
Lomond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company for treating hematological cancers | Health Technology |
Gwynant Therapeutics
Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Develops novel small molecules for oncology targets | Health Technology |
Venetian-1 Acquisition Corp.
Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | Health Technology |
Trawsfynydd Therapeutics, Inc.
Trawsfynydd Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing antiviral medicines | Commercial Services |
Eilean Therapeutics LLC
Eilean Therapeutics LLC Pharmaceuticals: MajorHealth Technology Engages in discovery and development of small molecule inhibitors therapies for hematological cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån